Ignite Creation Date:
2024-05-06 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05116761
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-12
First Post:
2021-11-09
Brief Title:
ExoFlo Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome
Sponsor:
Direct Biologics LLC
Organization:
Direct Biologics LLC
Organization Data
Organization:
Direct Biologics LLC
Class:
INDUSTRY
Study ID:
DB-EF-POSTCOVID-0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Direct Biologics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None